Skip to main content

MoneyWorks4Me

Wintac informs about quarterly statement on investor complaints

27 Jul 2016 Evaluate

Wintac has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1888.00
Dr. Reddys Labs. 1382.10
Cipla 1403.20
Lupin 2016.85
Zydus Lifesciences 1199.20
View more..